Cargando…
PLGA Particles in Immunotherapy
Poly(lactic-co-glycolic acid) (PLGA) particles are a widely used and extensively studied drug delivery system. The favorable properties of PLGA such as good bioavailability, controlled release, and an excellent safety profile due to the biodegradable polymer backbone qualified PLGA particles for app...
Autores principales: | Horvath, Dennis, Basler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965784/ https://www.ncbi.nlm.nih.gov/pubmed/36839937 http://dx.doi.org/10.3390/pharmaceutics15020615 |
Ejemplares similares
-
Thermosensitive PLGA–PEG–PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy
por: Heine, Sonja, et al.
Publicado: (2022) -
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
por: Koerner, Julia, et al.
Publicado: (2021) -
Glass Transition Temperature of PLGA Particles and the Influence on Drug Delivery Applications
por: Liu, Guangliang, et al.
Publicado: (2022) -
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
por: Silva, A. L., et al.
Publicado: (2016) -
Simulation of Drug Release from PLGA Particles In Vivo
por: Sasaki, Kaori, et al.
Publicado: (2013)